Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Adrenoleukodystrophy: genetics, phenotypes, pathogenesis, and treatment].

Annali dell'Istituto superiore di sanita - 1 Jan 1999

Di Biase A, Avellino C, Salvati S

Abstract excerpt

Adrenoleukodystrophy is a genetically determined disorder inherited as an X-linked recessive trait due to the defective peroxisomal oxydation of very long chain fatty acids (VLCFA). It is hallmarked by demyelination of the central nervous system and adrenal insufficiency. Even though the studies concerning the molecular basis of the disease are in progress, the role of VLCFA in the demyelination is still unclear....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenoleukodystrophy
Share to ATP Binding Cassette Transporter, Subfamily D, Member 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ATP-Binding Cassette Transporters

Share to Coenzyme A Ligases

Share to Genetic Markers

Share to Point Mutation

Share to Repressor Proteins

Share to Saccharomyces cerevisiae Proteins

Source

Identifiers

PMID: 10645651

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Adrenoleukodystrophy: genetics, phenotypes, pathogenesis, and treatment].PMID 10645651Read ↗

X-linked adrenoleukodystrophy: first report of the Italian Study Group.Semantic proximity Read ↗

[X-linked adrenoleukodystrophy].Semantic proximity Read ↗

X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.Semantic proximity Read ↗

X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.Semantic proximity Read ↗

X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.Semantic proximity Read ↗

X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy.Semantic proximity Read ↗

Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies.Semantic proximity Read ↗

[Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].Semantic proximity Read ↗

Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapiesSemantic proximity Read ↗

X-linked adrenoleukodystrophy: pathogenesis and treatment.Semantic proximity Read ↗

X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies.Semantic proximity Read ↗

ABCD1 and X-linked adrenoleukodystrophy: A disease with a markedly variable phenotype showing conserved neurobiology in animal models.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.